VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 64 filers reported holding VENTYX BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $126,008,080 | +19.1% | 3,628,220 | +12.4% | 0.00% | +33.3% |
| Q2 2023 | $105,831,562 | +54.2% | 3,226,572 | +57.5% | 0.00% | +50.0% |
| Q1 2023 | $68,628,135 | +6.2% | 2,048,601 | +4.0% | 0.00% | 0.0% |
| Q4 2022 | $64,591,809 | +33.9% | 1,969,863 | +42.6% | 0.00% | 0.0% |
| Q3 2022 | $48,230,000 | +273.0% | 1,381,503 | +30.7% | 0.00% | – |
| Q2 2022 | $12,929,000 | +93.9% | 1,057,189 | +115.2% | 0.00% | – |
| Q1 2022 | $6,667,000 | -32.1% | 491,336 | -0.7% | 0.00% | – |
| Q4 2021 | $9,826,000 | – | 494,702 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 2,298,833 | $77,010,906 | 42.68% |
| Qiming U.S. Ventures Management, LLC | 746,370 | $25,003,395 | 30.26% |
| TCG Crossover Management, LLC | 815,724 | $27,326,754 | 5.33% |
| ACUTA CAPITAL PARTNERS, LLC | 208,500 | $6,984,750 | 5.15% |
| Affinity Asset Advisors, LLC | 260,008 | $8,710,268 | 2.88% |
| Avidity Partners Management LP | 1,917,800 | $64,246,300 | 2.13% |
| Integral Health Asset Management, LLC | 290,000 | $9,715,000 | 1.96% |
| Tri Locum Partners LP | 152,842 | $5,120,207 | 1.56% |
| Vivo Capital, LLC | 602,075 | $20,169,513 | 1.40% |
| Boxer Capital, LLC | 850,000 | $28,475 | 1.40% |